Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001193125-26-355493

Chief Financial Officer sold 17,717 shares at $19.74 ($349,734)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Catinazzo Thomas · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-08-14 Sale : show line 1 in the form 10b5-1 −17,717 $19.74 $349,734 140,568 D
Open-market sales · 17,717 sh · avg $19.74 · $349,734
Loading xslF345X06/ownership.xml…